Solara Active Pharma reports Q2 profit, H1 profit jumps sharply
In short
Solara Active Pharma Sciences reported a consolidated net profit of ₹28.59 crore in Q2FY27 and ₹44.70 crore in H1FY27. That compares with a loss of ₹9.29 crore in Q2FY26 and a profit of ₹0.42 crore in H1FY26.
This matters because the results point to a strong turnaround and the share price jumped 16%. The report does not say what caused the improvement or whether it can continue.
What the reporting says
Solara Active Pharma Sciences reported a consolidated net profit of ₹28.59 crore in Q2FY27 and ₹44.70 crore in H1FY27, according to the publisher-supplied summary. It compared with a loss of ₹9.29 crore in Q2FY26 and profit of ₹0.42 crore in H1FY26, showing a sharp turnaround year on year. The report links the stock’s 16% rise to these results, but does not give guidance or drivers.
Why it matters
Solara Active Pharma Sciences posted a major earnings turnaround, with Q2FY27 net profit at ₹28.59 crore and H1FY27 net profit at ₹44.70 crore. The publisher-supplied summary contrasts this with a Q2FY26 loss and minimal H1FY26 profit, which appears to have supported the 16% share price move. The market focus is on profitability recovery, but the report does not identify the drivers or outlook.